"72626-2601-1" National Drug Code (NDC)

NDC Code	72626-2601-1
Package Description	2 BLISTER PACK in 1 CARTON (72626-2601-1) > 14 TABLET, FILM COATED in 1 BLISTER PACK
Product NDC	72626-2601
Product Type Name	HUMAN PRESCRIPTION DRUG
Proprietary Name	Ledipasvir And Sofosbuvir
Non-Proprietary Name	Ledipasvir And Sofosbuvir
Dosage Form	TABLET, FILM COATED
Usage	ORAL
Start Marketing Date	20190101
Marketing Category Name	NDA AUTHORIZED GENERIC
Application Number	NDA205834
Manufacturer	Asegua Therapeutics LLC
Substance Name	LEDIPASVIR; SOFOSBUVIR
Strength	90; 400
Strength Unit	mg/1; mg/1
Pharmacy Classes	Breast Cancer Resistance Protein Inhibitors [MoA], Hepatitis C Virus NS5A Inhibitor [EPC], Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC], Nucleoside Analog [EXT], P-Glycoprotein Inhibitors [MoA], RNA Replicase Inhibitors [MoA]